Persist AI, a Woodland, CA-based AI-driven drug formulation company, raised $4M in funding following their completion of YCombinator.
The round was led by 2048 Ventures with participation from Innospark Ventures, Fellows Fund, YCombinator, Pioneer Fund, and others.
The company intends to use the funds to expand operations and its development efforts.
Led by CEO Karthik Raman, Persist AI has developed robotics that enables automated development of long-acting injectable formulations. Coupled with AI models, they are able to rapidly predict which formulations will release drugs in the body for a long time and reduce the number of injections that patients need.
FinSMEs
04/08/2023